BioRestorative Therapies Announces New Initiative to Target Polycystic Ovarian Syndrome

    NEXT STORY
    T2 Biosystems Receives Funding from BARDA to Advance Technology for Diagnosis and Treatment of Bloodstream Infections
    PREV STORY
    Athenex Announces Initiation of Phase I Clinical Study in China of KX2-361 Oral by Partner Guangzhou Xiangxue Pharmaceutical
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Retrotope Announces Completion of Enrollment in Phase 2 Study of RT001 in Patients with Amyotrophic Lateral Sclerosis (ALS)

    author_avatar
    NASDAQ Market News

    Principia Biopharma Appoints Dolca Thomas, M.D. as Chief Medical Officer

    - Succession designed to lead Principia through next phase of growth as a clinical-stage company ...

    author_avatar
    NASDAQ Market News

    Global NGS-Based Monitoring & Diagnostic Test Market Outlook, 2019-2028 – Massive Scope for Adoption of NGS-Based Monitoring & Diagnostic Tests in Emerging Nations

    author_avatar
    NASDAQ Market News